Optimal use of tacrolimus in living donor renal transplantation in children.
Hasegawa
A
A
Department of Nephrology, Toho University, School of Medicine, 6-11-1 Omorinishi, Otaku, Tokyo, Japan.
Takahashi
K
K
Ito
K
K
Oshima
S
S
Uchida
K
K
Sonoda
T
T
D000293:Adolescent; D001682:Biological Availability; D002648:Child; D002675:Child, Preschool; D004435:Eating / Q000502:physiology; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus